| Schedule of share based compensation stock option activity |
| Schedule of share based compensation stock option activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Options Outstanding |
|
Weighted |
|
|
| |
|
Number of |
|
Weighted Average |
|
Average Remaining life |
|
Fair value of |
| |
|
Options |
|
Exercise Price |
|
(years) |
|
option |
| |
|
|
|
|
|
|
|
|
| Outstanding, January 1, 2025 |
|
|
|
213,904 |
|
|
$ |
29.30 |
|
|
|
5.04 |
|
|
|
1,708,693 |
|
| Granted |
|
|
|
72,000 |
|
|
|
2.71 |
|
|
|
— |
|
|
|
98,371 |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
| Expired |
|
|
|
(4,358 |
) |
|
|
(27.75 |
) |
|
|
— |
|
|
|
(52,669 |
) |
| Forfeited/canceled |
|
|
|
(10,917 |
) |
|
|
(3.16 |
) |
|
|
— |
|
|
|
(18,356 |
) |
| Outstanding, September 30, 2025 |
|
|
|
270,629 |
|
|
$ |
23.30 |
|
|
|
7.94 |
|
|
|
1,736,039 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable options, September 30, 2025 |
|
|
|
165,418 |
|
|
$ |
35.17 |
|
|
|
7.15 |
|
|
|
1,519,367 |
|
| |
|
Options Outstanding |
|
Weighted |
|
|
| |
|
Number of
Options |
|
Weighted Average
Exercise Price |
|
Average Remaining life
(years) |
|
Grant Date Fair
value of option |
| |
|
|
|
|
|
|
|
|
| Outstanding, January 1, 2024 |
|
|
|
127,093 |
|
|
$ |
39.85 |
|
|
|
8.04 |
|
|
|
2,213,178 |
|
| Granted |
|
|
|
74,199 |
|
|
|
6.31 |
|
|
|
— |
|
|
|
233,957 |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Expired |
|
|
|
(33,888 |
) |
|
|
(38.73 |
) |
|
|
— |
|
|
|
(578,873 |
) |
| Forfeited/canceled |
|
|
|
(12,284 |
) |
|
|
(12.80 |
) |
|
|
— |
|
|
|
(157,292 |
) |
| Outstanding, September 30, 2024 |
|
|
|
155,120 |
|
|
$ |
24,85 |
|
|
|
8.25 |
|
|
|
1,710,970 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable options, September 30, 2024 |
|
|
|
77,339 |
|
|
$ |
41.61 |
|
|
|
7.24 |
|
|
$ |
1,396,557 |
|
|
| Schedule of restricted stock options |
| Schedule of restricted stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Restricted Stock Units Outstanding |
|
|
|
|
| |
|
Number of |
|
Weighted Average
Grant – Date |
|
Weighted Average
Remaining life |
|
Aggregate Intrinsic |
| |
|
Units |
|
Fair Value Price |
|
(years) |
|
Value |
| |
|
|
|
|
|
|
|
|
| Outstanding, January 1, 2025 |
|
|
|
7,567 |
|
|
$ |
15.98 |
|
|
|
1.58 |
|
|
$ |
20,734 |
|
| Granted |
|
|
|
8,900 |
|
|
|
4.40 |
|
|
|
— |
|
|
|
24,386 |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Forfeited/canceled |
|
|
|
(3,415 |
) |
|
|
6.86 |
|
|
|
— |
|
|
|
(9,357 |
) |
| Outstanding, September 30, 2025 |
|
|
|
13,032 |
|
|
$ |
10.04 |
|
|
|
1.89 |
|
|
$ |
35,763 |
|
| |
|
Restricted Stock
Units Outstanding |
|
|
|
|
| |
|
Number of |
|
Weighted Average
Grant – Date |
|
Weighted Average
Remaining life |
|
Aggregate Intrinsic |
| |
|
Units |
|
Fair Value Price |
|
(years) |
|
Value |
| |
|
|
|
|
|
|
|
|
| Outstanding, January 1, 2024 |
|
|
|
6,725 |
|
|
$ |
22.50 |
|
|
|
2.07 |
|
|
$ |
40,350 |
|
| Granted |
|
|
|
8,730 |
|
|
|
8.38 |
|
|
|
— |
|
|
|
52,380 |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Forfeited/canceled |
|
|
|
(6,611 |
) |
|
|
(13.19 |
) |
|
|
|
|
|
|
(39,666 |
) |
| Outstanding, September 30, 2024 |
|
|
|
8,844 |
|
|
$ |
15.52 |
|
|
|
1.82 |
|
|
$ |
53,064 |
|
|